![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1662-6575|3|1|59-62
ISSN: 1662-6575
Source: Case Reports in Oncology, Vol.3, Iss.1, 2010-03, pp. : 59-62
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Optimizing the Use of Oral Anti-Neoplastic Drug Therapy
Oncology, Vol. 84, Iss. 2, 2012-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Use of Systemic Antineoplastic Drug Therapy after Regulatory Agency Approval
Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chloroquine enjoys a renaissance as an antineoplastic therapy
By Espina Virginia Liotta Lance A
Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Value anti–hepatitis C virus therapy by its clinical efficacy
HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. :